Invesaro

Stocks Finance DMII

NASDAQ · Finance

Drugs Made In America Acquisition II Corp. (DMII)

At June 30, 2026 it held $175K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Price
$10.16
+0.10% on the day · September 25, 2026
52-week range $9.86 to $10.33
Market cap
$647.2M

What Drugs Made In America Acquisition II Corp. does

Drugs Made In America Acquisition II Corp. is registered with the SEC under industry code SIC 6770 (Blank Checks). Its shares trade on NASDAQ under the ticker DMII.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025n/a-$488.4K$4.2Mn/an/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 13, 2026.

Estimated from its filing rhythm: about 92 days after its last report of August 14, 2026, its usual gap. Not a date the company has announced. See the report calendar

Latest SEC filings

What Drugs Made In America Acquisition II Corp. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Net income of $4.4M versus a net loss of $38.1K.
  2. May 14, 2026
    Quarterly report 10-Q · period to March 31, 2026Net income of $4.3M versus a net loss of $59.3K.
  3. April 28, 2026
    Material agreement 8-K
  4. April 15, 2026
    Annual report 10-K · period to December 31, 2025Net income was $4.2M.
  5. April 3, 2026
    Material agreement 8-K
  6. April 1, 2026
    Late annual report notice NT 10-K
  7. March 17, 2026
    Material agreement 8-K
  8. March 6, 2026
    Other event 8-K
  9. March 6, 2026
    Executive or director change 8-K
  10. November 18, 2025
    Quarterly report 10-Q · period to September 30, 2025Net loss of $46.2K.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 17, 2025. Insider transactions on SEC

All filings on SEC EDGAR

Questions about DMII

What does Drugs Made In America Acquisition II Corp. do?

Drugs Made In America Acquisition II Corp. is registered with the SEC under industry code SIC 6770 (Blank Checks). Its shares trade on NASDAQ under the ticker DMII.

Is Drugs Made In America Acquisition II Corp. profitable?

Yes. Over the twelve months to June 30, 2026 it reported net income of $13M.

When did Drugs Made In America Acquisition II Corp. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.

Similar companies

IPCX
Inflection Point Acquisition Corp. III
AVNI
Arvana Inc
MTAL
Metals Acquisition Corp. II
HCMA
Hcm III Acquisition Corp.
TACO
Berto Acquisition Corp.
CUB
Lionheart Holdings

Compare DMII with

Compare DMII with any company

Follow DMII

Get an email when Drugs Made In America Acquisition II Corp. files with the SEC: results, executive changes, material agreements and annual reports.

Follow DMII: get an email when it files

Where the numbers come from

Financial figures are the values Drugs Made In America Acquisition II Corp. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.